Acadia Healthcare (1ACHC) AI Stock Analysis

Acadia Healthcare

(Milan:1ACHC)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Capacity ExpansionPlanned bed additions and new joint-venture facilities expand Acadia’s revenue capacity in a growing behavioral-health network. New cohorts are outperforming start-up targets, suggesting disciplined execution and a pathway for recently added assets to contribute increasingly attractive earnings.

Negative Factors

Profitability DeteriorationThe sharp swing from profitability to a large TTM net loss indicates that current earnings power is weak and volatile. Revenue contraction compounds the issue, making it harder for operating leverage to emerge and increasing the importance of successful facility ramps and cost control.

Acadia Healthcare (1ACHC) vs. iShares MSCI Italy ETF (EWI)

Market Cap: EUR 2.79B
Dividend Yield: ―
Average Volume (3M): 185
Price to Earnings (P/E): -2.4
Beta (1Y): 0.27
Revenue Growth: -2.69%
EPS Growth: -869.61%
Country: Italy
Employees: 25,000
Sector: Healthcare
Sector Strength: 51
Industry: Medical - Care Facilities

Acadia Healthcare Business Overview & Revenue Model

Company Description

Acadia Healthcare Company, Inc. specializes in delivering a comprehensive range of behavioral health services, with its operations spanning the United States and Puerto Rico. Patients receive care in diverse environments, including acute inpatient ps...

Acadia Healthcare Earnings Call Summary

Earnings Call Date:Jul 27, 2026(Q2-2026)|% Change Since:-7.69%|Next Earnings Date:Nov 03, 2026

Earnings Call SentimentPositive

The call was predominantly positive: management reported results at or above guidance, strong free cash flow, substantial debt reduction, improving performance from new facilities, operational gains, and confidence in the full-year outlook. Offsetting issues included flat reported revenue, the impact of New York Medicaid changes, a significant professional liability reserve adjustment, CTC performance below expectations, start-up losses, and uncertainty around government investigation costs. The highlights significantly outweighed the lowlights.

Positive Updates

Revenue and Earnings Performance Met or Exceeded Guidance

Second-quarter revenue was above the high end of guidance, while adjusted EBITDA and adjusted EPS were near the high end of guidance. Adjusted EBITDA was $149.2 million.

Negative Updates

Reported Revenue Was Flat Year-over-Year

Second-quarter revenue was $866 million, flat compared with the prior-year period. Same-facility revenue was also flat year-over-year, with a 0.8% increase in patient days offset by a 0.8% decrease in revenue per patient day.

Company Guidance

Acadia updated its full year guidance to revenue in a range of $3.4 billion to $3.45 billion, adjusted EBITDA in a range of $590 million to $615 million, adjusted EPS in a range of $1.45 to $1.60 and operating cash flow in a range of $350 million to $400 million; full-year CapEx is expected in a range of $235 million to $255 million, including a range of $120 million to $140 million for the second half of the year, with positive free cash flow in the second half of 2026, 500 to 600 beds added in 2026, and supplemental payment programs in Florida and Ohio that could add more than $20 million in incremental EBITDA, while guidance includes a $5 million historical baseline amount for Florida in Q3 expectations.

Acadia Healthcare Risk Analysis

Acadia Healthcare disclosed 55 risk factors in its most recent earnings report. Acadia Healthcare reported the most risks in the "Finance & Corporate" category.

Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

0 New Risks

Acadia Healthcare Peers Comparison

Overall Rating

UnderperformOutperform

Sector (51)

Financial Indicators

IT:1ACHC against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
HCSG	78Outperform	$1.65B	16.24	20.22%	―	3.96%	175.90%
LFST	69Neutral	$5.12B	102.92	3.39%	―	20.38%	―
UHS	68Neutral	$10.37B	7.30	19.54%	0.45%	8.00%	13.14%
HCA	61Neutral	$98.85B	57.42	-100.45%	0.65%	5.82%	16.59%
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
CYH	39Underperform	$338.46M	-0.62	36.02%	―	-7.84%	-88.93%

* Healthcare Sector Average

Performance Comparison

IT:1ACHC and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
IT:1ACHC	Acadia Healthcare Company, Inc.	26.40	8.30	45.86%
CYH	Community Health Systems	2.40	-1.45	-37.66%
HCA	Hca Healthcare	473.19	14.77	3.22%
HCSG	Healthcare Services Group	24.52	6.64	37.14%
UHS	Universal Health Services	176.05	-43.69	-19.88%
LFST	Lifestance Health Group, Inc.	13.40	8.48	172.36%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Acadia Healthcare AI Stock Analysis